ArticleBreast cancer research and treatment2024

The role of endocrine treatment on the risk of developing an ipsilateral invasive breast cancer in hormone receptor positive patients with ductal carcinoma in situ.

Kadri AltundagPubMed ↗Publisher ↗

No numbers read from the abstract.